Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

280
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
280
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

357
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
357
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

2.8K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
2.8K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

272
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
272
Pulmonary Function Tests01:25

Pulmonary Function Tests

340
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
340

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhaled Volume as a Digital Biomarker Predicting Outcomes in Chronic Respiratory Disease.

Journal of aerosol medicine and pulmonary drug delivery·2025
Same author

Uncovering patterns of inhaler technique and reliever use: the value of objective, personalized data from a digital inhaler.

NPJ primary care respiratory medicine·2024
Same author

Advancing Digital Solutions to Overcome Longstanding Barriers in Asthma and COPD Management.

Patient preference and adherence·2023
Same author

A Predictive Machine Learning Tool for Asthma Exacerbations: Results from a 12-Week, Open-Label Study Using an Electronic Multi-Dose Dry Powder Inhaler with Integrated Sensors.

Journal of asthma and allergy·2022
Same author

Investigating the Accuracy of the Digihaler, a New Electronic Multidose Dry-Powder Inhaler, in Measuring Inhalation Parameters.

Journal of aerosol medicine and pulmonary drug delivery·2021
Same author

The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients.

Journal of asthma and allergy·2020

Related Experiment Video

Updated: Jul 9, 2025

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

881

Dry Powder Inhalers: From Bench to Bedside.

Henry Chrystyn1, Wahida Azouz2, Walid Tarsin3

  • 1Inhalation Consultancy Ltd., Yeadon, Leeds, United Kingdom.

Journal of Aerosol Medicine and Pulmonary Drug Delivery
|November 28, 2023
PubMed
Summary

Dry powder inhalers (DPIs) offer advantages but patient inhalation technique significantly impacts delivered dose. Proper DPI use and training are crucial for effective medication delivery in respiratory conditions.

Keywords:
dose emissioninhalation flowinhalation maneuverresistance

More Related Videos

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.7K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.7K

Related Experiment Videos

Last Updated: Jul 9, 2025

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

881
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.7K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.7K

Area of Science:

  • Pharmaceutical Sciences
  • Respiratory Medicine
  • Medical Device Engineering

Background:

  • Dry powder inhalers (DPIs) are increasingly preferred over pressurized metered-dose inhalers (pMDIs) due to patient preference and perceived advantages.
  • However, the effectiveness of DPIs is highly dependent on patient-specific inhalation maneuvers and correct device handling.
  • Variations in lung disease severity influence a patient's ability to operate DPIs, affecting inhaled dose characteristics.

Purpose of the Study:

  • To elucidate the critical role of pharmaceutical science in understanding DPI functionality.
  • To emphasize the impact of patient inhalation technique and dose preparation on the actual inhaled dose from DPIs.
  • To highlight the necessity of proper training and verification of inhalation technique for optimal patient outcomes.

Main Methods:

  • Review of pharmaceutical science principles governing DPI function.
  • Analysis of how patient-specific factors (e.g., lung disease severity) influence inhalation maneuvers.
  • Examination of dose preparation routines unique to different DPI devices.

Main Results:

  • The characteristics of the emitted dose from a DPI are intrinsically linked to the patient's inhalation maneuver.
  • Inconsistent or incorrect dose preparation routines can lead to a complete failure in medication delivery.
  • Patient's lung disease severity directly impacts their inhaler usage patterns and the resultant inhaled dose.

Conclusions:

  • A thorough understanding of DPI pharmaceutical science is essential for appreciating the relevance of patient inhalation technique.
  • Adherence to specific dose preparation steps for each DPI is critical to ensure medication is inhaled.
  • Inhale technique training and regular checks are vital components of patient management; device switching or dose increases should only occur after confirming proper DPI use.